Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “TEVA PHARMACEUTICAL INDUSTRIES, LTD.”

302 pharma patents match "TEVA PHARMACEUTICAL INDUSTRIES, LTD." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 302
Index total 30,257
Page 8 / 13

Quick answer

This filtered view shows 302 pharmaceutical patents matching "TEVA PHARMACEUTICAL INDUSTRIES, LTD." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

302 results for “TEVA PHARMACEUTICAL INDUSTRIES, LTD.” · 30,257 patents in full index Clear search

  1. US 7534913

    Crystalline form of nateglinide

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted May 19, 2009 · Expires May 14, 2029

    granted
  2. US 7534900

    Process for the purification of duloxetine hydrochloride

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted May 19, 2009 · Expires May 14, 2029

    granted
  3. US 7514467

    Crystalline solids of carvedilol and processes for their preparation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 7, 2009 · Expires Apr 2, 2029

    granted
  4. US 7511174

    Solid and crystalline ibandronic acid

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 31, 2009 · Expires Mar 26, 2029

    granted
  5. US 7507829

    Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 24, 2009 · Expires Mar 19, 2029

    granted
  6. US 7504504

    Methods of preparing aripiprazole crystalline forms

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 17, 2009 · Expires Mar 12, 2029

    granted
  7. US 7501450

    Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 10, 2009 · Expires Mar 5, 2029

    granted
  8. US 7501448

    Process for preparing telmisartan

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 10, 2009 · Expires Mar 5, 2029

    granted
  9. US 7495072

    Process for preparation of mixtures of polypeptides using purified hydrobromic acid

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 24, 2009 · Expires Feb 19, 2029

    granted
  10. US 7491847

    Methods for isolating propargylated aminoindans

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 17, 2009 · Expires Feb 12, 2029

    granted
  11. US 7488750

    Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 10, 2009 · Expires Feb 5, 2029

    granted
  12. US 7485663

    Carvedilol

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 3, 2009 · Expires Jan 29, 2029

    granted
  13. US 7473780

    Drying process for preparing crystalline solid famciclovir

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jan 6, 2009 · Expires Jan 1, 2029

    granted
  14. US 7468444

    Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 23, 2008 · Expires Dec 18, 2028

    granted
  15. US 7462737

    Pregabalin free of isobutylglutaric acid and a process for preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 9, 2008 · Expires Dec 4, 2028

    granted
  16. US 7456297

    Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 25, 2008 · Expires Nov 20, 2028

    granted
  17. US 7442806

    Processes for preparing darifenacin hydrobromide

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 28, 2008 · Expires Oct 23, 2028

    granted
  18. US 7435741

    2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 14, 2008 · Expires Oct 9, 2028

    granted
  19. US 7429374

    Process for the measurement of the potency of glatiramer acetate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Sep 30, 2008 · Expires Sep 25, 2028

    granted
  20. US 7420084

    Polymorphic forms of nateglinide

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Sep 2, 2008 · Expires Aug 28, 2028

    granted
  21. US 7417165

    Crystalline forms of pregabalin

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 26, 2008 · Expires Aug 21, 2028

    granted
  22. US 7417044

    Tadalafil having a large particle size and a process for preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 26, 2008 · Expires Aug 21, 2028

    granted
  23. US 7414140

    Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 19, 2008 · Expires Aug 14, 2028

    granted
  24. US 7411067

    Crystalline forms of gatifloxacin

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 12, 2008 · Expires Aug 7, 2028

    granted